Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Anaïs Debesset

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5010060790. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 4

  1. TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion. Co-author DOI 10.1136/jitc-2024-008898↗
  2. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. First author DOI 10.3390/cancers14174265↗
  3. Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265. First author DOI 10.3390/cancers14246160↗
  4. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13122986↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matteo Ponzo · 4 shared papers, 2021–2024 · strength 0.51
  2. José Laurent Cohen · 4 shared papers, 2021–2024 · strength 0.51
  3. Ilaria Cascone · 4 shared papers, 2021–2024 · strength 0.51
  4. Mounira Chalabi‐Dchar · 3 shared papers, 2021–2022 · strength 0.34
  5. Fabio Raineri · 3 shared papers, 2021–2022 · strength 0.34
  6. Philippe Bouvet · 3 shared papers, 2021–2022 · strength 0.34
  7. Rémy Nicolle · 2 shared papers, 2022 · strength 0.23
  8. Corinne Bousquet · 2 shared papers, 2022 · strength 0.23
  9. Christophe Tournigand · 2 shared papers, 2022 · strength 0.23
  10. Jerome F. Cros · 1 shared paper, 2021 · strength 0.11
  11. Anne Couvelard · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.